9 research outputs found
Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital
Aim Pertussis continues to be a common worldwide infection in pediatric and adult populations. We aimed to study epidemiological and clinical characteristics of infants and children admitted for pertussis to a tertiary-care hospital and to investigate the risk factors for pediatric intensive care unit (PICU) admission. Materials and Methods With a retrospective study, we analyzed all medical reports of patients admitted to Bambino Gesu Children's Hospital in Rome from January 2011 to December 2018 with a diagnosis of pertussis. Results We examined 195 patients. The majority of hospitalized children (66.15%) were <3 months of age. No mother had received pertussis containing vaccine during pregnancy. Ten cases required admission in PICU. The age at admission was lower in PICU patients with respect to ward patients (42.8 vs 240 days;p< .0007), length of hospital stay was longer in PICU group (24.7 vs 7.52 days;p< .003). Patients who needed PICU admission had greater white blood cell count at hospital admission compared with those hospitalized in the pediatric ward. One infant died and one had encephalitis. Conclusions Pertussis is a remerging disease. In infants, it is associated with significant morbidity and mortality. In recent years, many countries have implemented different vaccination strategies and public health measures to prevent the increase in pertussis cases. Maternal vaccination has been shown to be highly protective for infants <3 months of age before they can develop their own immunity via vaccination
Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost
Introduction: Respiratory syncytial virus (RSV) bronchiolitis is among the leading causes of hospitalization in infants. Prophylaxis with palivizumab may reduce RSV infection, but its prescription is restricted to high-risk groups. The aim of the study is to retrospectively determine acute hospitalization costs of bronchiolitis. Materials and methods: Infants aged 1 month-1 year, admitted to Bambino Gesu Children Hospital, Rome, Italy, with a diagnosis of bronchiolitis from January 1 till December 31, 2017, were included in the study. Results: A total of 531 patients were enrolled in the study, and the mean age was 78.75 days. The main etiologic agent causing bronchiolitis was RSV, accounting for 58.38% of infections. The total cost of bronchiolitis hospitalization was 2,958,786 euros. The mean cost per patient was significantly higher in the case of RSV (5,753.43 +/- 2,041.62 euros) compared to other etiology (5,395.15 +/- 2,040.87 euros) (p = 0.04). Discussion: The study confirms the high hospitalization cost associated with bronchiolitis. In detail, in the case of RSV etiology, the cost was higher compared to other etiology, which is likely due to the longer hospitalization and the more frequent admission to the intensive cure department. Conclusion: This study highlights that bronchiolitis is an important cost item even in a tertiary hospital and that cost-effective interventions targeting RSV are increasingly urgent
Re: Atrioventricular septal defect with common atrioventricular junction, common arterial trunk and severe coartation of the aorta in a patient with Down's syndrome.
Active prophylaxis for respiratory syncytial virus: Current knowledge and future perspectives
Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and young children but represents also an important cause of morbidity in adults, particularly in the elderly and immunocompromised persons. Despite its global impact on human health, no effective treatment is available except for supportive care and no safe vaccine has been licensed yet. Vaccine development has been hindered by several factors including vaccine enhanced disease associated with formalin-inactivated RSV vaccine, ethical concerns and lack of consensus concerning the most appropriate target antigen. In this review, we analyze history of RSV vaccine and current approaches for preventing RSV including live-attenuated, vector-based, subunit, nucleic acid-based, particle-based vaccines and we debate about concerns on target population, correlates of protection and obstacles that are slowing the progress toward a successful RSV vaccination strategy
. Serum Soluble ST2 as Diagnostic Marker of Systemic Inflammatory Reactive Syndrome of Bacterial Etiology in Children.
Accurate and timely diagnosis of community-acquired bacterial
versus viral infections in children with systemic inflammatory response
syndrome (SIRS) remains challenging both for clinician and laboratory. In the
quest of new biochemical markers to distinguish bacterial from viral infection,
we have explored the possible role of the soluble secreted form of ST2 (sST2).
Methods: This explorative prospective cohort study included children with
SIRS who were suspected of having community-acquired infections. Plasma
samples for sST2 measurement were obtained from 64 hospitalized children,
41 of whom had SIRS of bacterial etiology and 23 SIRS of viral etiology,
and from 20 healthy, age- and sex-matched control children. sST2 measurement
was carried out by enzyme-linked immunosorbent assay in parallel with
standard measurements of procalcitonin (PCT) and C reactive protein (CRP).
Results: Our findings demonstrate that children with SIRS associated with
bacterial infection present significantly increased levels of sST2, when
compared with patients with SIRS of viral etiology and healthy children.
More important, receiver operating characteristic curve analysis indicated
that sST2 has a significant diagnostic performance with respect to early
identification of SIRS of bacterial etiology, which was similar to that of
PCT and greater than that of CRP. Finally, the combination of sST2 plus
PCT and/or CRP, and PCT plus CRP increased their sensitivity and negative
predictive value compared with sST2, PCT and CRP alone.
Conclusions: In conclusion, sST2 level may prove useful in predicting bacterial
etiology in children with SIR
Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy
An agent-based model of innovation diffusion: network structure and coexistence under different information regimes
The paper analyzes how the structure of social networks affects innovation diffusion and competition under different information regimes. Diffusion is modeled as the result of idiosyncratic adoption thresholds, local network effects and information diffusion (broadcasting and demonstration effect from previous adopters). A high social cohesion decreases the probability of one innovation cornering the market. Nonetheless, with imperfect information, in small-world networks the higher speed of diffusion produced by the low average distance increases this probability. A low social cohesion also increases the probability of falling into traps of under-adoption. However, such probability is significantly lower with imperfect information, because such regime is characterized by higher levels of market concentrations and this reduces the frictions due to the coexistence of non-compatible product innovations.<br/